Tavares M., Kozak M., Balola A., Sá-Correia I. Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products. Clin Microbiol Rev. 2020;33(3):139.

Trần Minh Giao. Khảo sát đặc điểm nhiễm Burkholderia cepacia tại bệnh viện nhân dân Gia Định. Tạp chí Y học Thành phố Hồ Chí Minh. 2009;13(6):112-121.

Diệp Thế Tài, Lưu Trúc Viên, Nguyễn Mai Thủy Tiên, Nguyễn Hồng Lạc, Nguyễn Quốc Duy. Thực trạng nhiễm và kháng kháng sinh của Burkholderia pseudomallei và Burkholderia cepacia tại bệnh viện đa khoa khu vực Củ Chi – thành phố Hồ Chí Minh năm 2017 – 2018. Tạp chí Y học Dự Phòng. 2019;29(5):101.

Häfliger E., Atkinson A., Marschall J. Systematic review of healthcare-associated Burkholderia cepacia complex outbreaks: presentation, causes and outbreak control. Infect Prev Pract. 2020;2(3):100082.

Huang C.H., Jang T.N., Liu C.Y., Fung C.P., Yu K.W., Wong W.W. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect. 2001;34(3):215-9.

Wu H., Huang D., Wu B., Pan M. Fatal deep venous thrombosis and pulmonary embolism secondary to melioidosis in China: case report and literature review. BMC Infect Dis. 2019;19(1):984.

Raffini L.J., Raybagkar D., Blumenstein M.S., Rubenstein R.C., Manno C.S. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J Pediatr. 2006;148(5):659-64.

Vervloet M.G., Thijs L.G., Hack C.E. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost. 1998;24(1):33-44.

Jones A.M., Dodd M.E., Govan J.R., Barcus V. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax. 2004;59(11):948-51.

Mori P.G., Acquila M., Bicocchi M.P., Bottini F. More on the relationship between cystic fibrosis and venous thrombosis. Eur J Haematol. 2000;65:82-3.

Hernández-Espinosa D., Ordóñez A., Miñano A., Martínez-Martínez I. Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes. Thromb Res. 2009;124(4):483-9.

Blanchard F., Charbit J., Van der Meersch G., Popoff B. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care. 2020;10(1):58.

Nash E.F., Helm E.J., Stephenson A., Tullis E. Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J Vasc Interv Radiol. 2009;20(3):347-51.

Mukhtharahmed B., Peter G. Burkholderia cepacia - An unusual organism for sepsis in ICUs. Journal of Clinical and Diagnostic Research. 2011;5(6):1281-1282.

Peralta D.P., Chang A.Y., Ariza-Hutchinson A., Ho C.A. Burkholderia multivorans: A rare yet emerging cause of bacterial meningitis. IDCases. 2018;11:61-63.

Baul S.N., De R., Mandal P.K., Roy S. Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern India. Mediterr J Hematol Infect Dis. 2018;10(1):2018051.

Ku N.S., Han S.H., Kim C.O., Baek J.H., Jeong S.J. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia. Scand J Infect Dis. 2011;43(10):792-7.

Martin-Loeches I., Guia M.C., Vallecoccia M.S., Suarez D. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care. 2019;9(1):26.

Kazachkov M., Lager J., LiPuma J., Barker P.M. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr Pulmonol. 2001;32(4):338-40.

Weidmann A., Webb A.K., Dodd M.E., Jones A.M. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy. J Cyst Fibros. 2008;7(5):409-11.

Ottu Para N.K., Vemuri S., Koshy G., Ibrahim D. Management of Cepacia syndrome in an immunocompetent non-cystic fibrosis adult patient. Int J Infect Dis. 2022;122:550-552.